Glaucacetalin E and galphimidin B from Galphimia glauca and their anxiolytic activity.


Journal

Journal of ethnopharmacology
ISSN: 1872-7573
Titre abrégé: J Ethnopharmacol
Pays: Ireland
ID NLM: 7903310

Informations de publication

Date de publication:
15 Sep 2020
Historique:
received: 19 11 2019
revised: 21 04 2020
accepted: 29 04 2020
pubmed: 18 5 2020
medline: 26 2 2021
entrez: 18 5 2020
Statut: ppublish

Résumé

Galphimia glauca is a Mexican medicinal plant used to treat anxiety, fear, phobia and stress as it possesses sedative properties which produce a calming effect. Although some chemical and pharmacological studies have already been carried out on G. glauca, there are still new chemical entities from this plant whose anxiolytic activity should be established. To validate the use of G. glauca growing in Cuernavaca, Morelos, as an anti-stress agent, through the purification and structural identification of its extracts' chemical constituents; the analysis of the biogenetic relationship of its chemical compounds, and its biological evaluation to demonstrate its traditional use as anxiolytic agents. The structures of all isolated compounds were established based on their spectroscopic and spectrometric data. The structure of compound 2 was corroborated through X-Ray. The anxiolytic and sedative-like activities were assessed by the open-field, hole-board and exploration cylinder test. The nor-triterpenes glaucacetalin E (1) and galphimidin B (2) were isolated for the first time along with seven other known compounds, one of them galphimidin (3), from the CHCl Our results suggest that G. glauca growing in Cuernavaca, Morelos, exerts anxiolytic-like activity due to the presence of the nor-triterpenes 1-3. These results reinforce the potential use of this species in the treatment of anxiety.

Identifiants

pubmed: 32417425
pii: S0378-8741(19)34595-7
doi: 10.1016/j.jep.2020.112939
pii:
doi:

Substances chimiques

Anti-Anxiety Agents 0
Anticonvulsants 0
Galphimia glauca extract 0
Hypnotics and Sedatives 0
Plant Extracts 0
Pentylenetetrazole WM5Z385K7T

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

112939

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare no conflicts of interest.

Auteurs

María Yolanda Rios (MY)

Centro de Investigaciones Químicas, IICBA, Universidad Autónoma Del Estado de Morelos, Cuernavaca, 62209, Morelos, Mexico. Electronic address: myolanda@uaem.mx.

Alfredo Ortega (A)

Instituto de Química, Universidad Nacional Autónoma de México, Mexico.

Blanca Domínguez (B)

Centro de Investigaciones Químicas, IICBA, Universidad Autónoma Del Estado de Morelos, Cuernavaca, 62209, Morelos, Mexico.

Myrna Déciga (M)

Sección de Estudios de Posgrado e Investigación de la Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico.

Vianey de la Rosa (V)

Centro de Investigaciones Químicas, IICBA, Universidad Autónoma Del Estado de Morelos, Cuernavaca, 62209, Morelos, Mexico.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH